Abstract
摘要
相似文献
1
FDA approves marketing of octreotide.美国食品药品监督管理局批准奥曲肽上市销售。
Clin Pharm. 1989 Jan;8(1):4.
2
[The treatment of carcinoid of the small intestine with octreotide and alpha-interferon. A call for participation in a randomized study].[奥曲肽和α-干扰素治疗小肠类癌。呼吁参与一项随机研究]
Dtsch Med Wochenschr. 1996 May 31;121(22):744-5.
3
[New medical therapy of neuroendocrine gastrointestinal tumors].[神经内分泌性胃肠道肿瘤的新医学疗法]
Lakartidningen. 1990 Aug 29;87(35):2668-72.
4
[Carcinoid of the small intestine and hemorrhagic diathesis].
Dtsch Med Wochenschr. 1970 May 8;95(19):1083-4.
5
[Chronic diarrhea and carcinoid].[慢性腹泻与类癌]
Arch Fr Mal App Dig. 1971 Jan-Feb;60(1):59-60.
6
Carcinoid tumor and intravenous octreotide infusion during labor and delivery.分娩期间的类癌肿瘤与静脉注射奥曲肽
Int J Obstet Anesth. 2009 Apr;18(2):182-5. doi: 10.1016/j.ijoa.2008.10.005. Epub 2009 Feb 5.
7
A pressing situation.一个紧迫的情况。
Am J Med. 2005 Dec;118(12):1347-9. doi: 10.1016/j.amjmed.2005.02.043.
8
[Carcinoid tumor of the small intestine].[小肠类癌肿瘤]
Acta Gastroenterol Belg. 1971 Jun;34(6):507-17.
9
[Carcinoid syndrome. Tryptophan metabolism--pathogenesis of concomitant symptoms--combination of tumours].[类癌综合征。色氨酸代谢——伴随症状的发病机制——肿瘤的联合]
Munch Med Wochenschr. 1972 May 19;114(20):973-8.
10
Chronic treatment with a long-acting somatostatin analogue in a patient with intestinal carcinoid tumor: occurrence of cholelithiasis.长效生长抑素类似物对肠类癌肿瘤患者的长期治疗：胆石症的发生
J Endocrinol Invest. 1990 Jan;13(1):69-72. doi: 10.1007/BF03348589.
引用本文的文献
1
Somatostatin receptor expression on von Hippel-Lindau-associated hemangioblastomas offers novel therapeutic target.希佩尔-林道相关性血管母细胞瘤上生长抑素受体的表达为新的治疗靶点。
Sci Rep. 2017 Jan 17;7:40822. doi: 10.1038/srep40822.
Zotero 插件